HUM vs RIGL
Humana Inc (HUM) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the HUM and RIGL stock pages for the full models.
Not investment advice.